JPX · 4596.T
Kubota Pharmaceutical Holdings Co., Ltd.
¥57-¥1 (-1.72%)
Kubota Pharmaceutical Holdings Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 83.71% below the high.
Loading market information…
OTC · DIZTF · USD
Stock price, earnings
Quote as of Jun 25, 2025, 12:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Dignitana AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 1.89% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Dignitana AB (publ)’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Dignitana AB (publ) operates as a medical technology enterprise, concentrating on the creation, production, and global distribution of specialized medical cooling devices, with significant activity in the United States. Its flagship product is DigniCap, a scalp cooling system specifically engineered to mitigate hair loss that can arise from particular chemotherapy protocols, notably those employed in breast cancer treatment. The company was established in 2007 and is headquartered in Lund, Sweden.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:57 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q2 2023 | Aug 17, 2023 | -$0.01 | $1.95M-18.85% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
¥57-¥1 (-1.72%)
Kubota Pharmaceutical Holdings Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 83.71% below the high.
$0.00$0.00 (0.0%)
Yourgene Health Plc: Healthcare · Medical - Diagnostics & Research.
€2.93-€0.12 (-3.93%)
Biofrontera AG’s quoted price sits in the lower half of its reported 52-week range, 43.44% below the high.
$0.01-$0.04 (-76.0%)
Antisense Therapeutics Limited’s quoted price sits in the lower half of its reported 52-week range, 84.0% below the high.
$0.13+$0.00 (+2.84%)
HQDA Elderly Life Network Corp.: Healthcare · Medical - Care Facilities.
$0.23-$0.00 (-1.74%)
Think Research Corporation’s quoted price sits in the lower half of its reported 52-week range, 37.24% below the high.
$0.98$0.00 (0.0%)
American Hemp Ventures, Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.82% below the high.
$0.82+$0.78 (+2,173.99%)
Titan Medical Inc.’s quoted price sits in the upper half of its reported 52-week range, 18.25% below the high.
